Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MOREPEN LABS Gains 7%; BSE HEALTHCARE Index Down 0.5%
Mon, 9 Sep 14:16

MOREPEN LABS Gains 7%; BSE HEALTHCARE Index Down 0.5%Image source: phive2015/www.istockphoto.com

MOREPEN LABS share price has zoomed 7% and is presently trading at Rs 95.9.

Meanwhile, the BSE HEALTHCARE index is at 43,262.6 (down 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 8.9%) and HIKAL CHEMIC (up 7.5%).

MAX HEALTHCARE INSTITUTE (down 2.8%) and GRANULES INDIA (down 2.7%) are among the top losers today.

Over the last one year, MOREPEN LABS has moved up from Rs 40.0 to Rs 95.9, registering a gain of Rs 56.0 (up 140.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,163.1 to 43,262.6, registering a gain of 53.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 133.4%), Jubilant Pharmova (up 124.0%) and GRANULES INDIA (up 114.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,392.8 (up 0.3%).

The top gainers among the BSE Sensex today are Hindustan Unilever (up 3.0%) and ITC (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,893.5 (up 0.2%). Hindustan Unilever and ITC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,780.3 to 81,392.8, registering a gain of 15,612.5 points (up 23.7%).

MOREPEN LABS Financial Update...

MOREPEN LABS net profit grew 147.2% YoY to Rs 362 million for the quarter ended June 2024, compared to a profit of Rs 146 million a year ago. Net sales rose 13.5% to Rs 4,552 million during the period as against Rs 4,010 million in April-June 2023.

For the year ended March 2024, MOREPEN LABS reported 149.8% increase in net profit to Rs 966 million compared to net profit of Rs 387 million during FY23. Revenue of the company grew 19.3% to Rs 16,904 million during FY24.

The current Price to earnings ratio of MOREPEN LABS, based on rolling 12 month earnings, stands at 44.5.


Equitymaster requests your view! Post a comment on "MOREPEN LABS Gains 7%; BSE HEALTHCARE Index Down 0.5%". Click here!